• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Loss of ARID1A, a tumor suppressor gene, expression is related to the mechanism of chemoresistance in ovarian clear cell carcinoma

Research Project

  • PDF
Project/Area Number 23791844
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Obstetrics and gynecology
Research InstitutionShimane University

Principal Investigator

ISHIKAWA MASAKO  島根大学, 医学部, 助教 (50467718)

Project Period (FY) 2011 – 2013
Keywords癌 / ゲノム / 癌抑制遺伝子
Research Abstract

Recently, the ARID1A gene has been identified as a novel tumor suppressor in ovarian clear cell carcinoma (OCCC). The current study was designed to evaluate whether ARID1A was a prognostic factor for progression, survival, and chemoresistance in OCCC. Loss of ARID1A expression was identified in 9 (15.0%) of 60 OCCC samples. Loss of ARID1A correlated with shorter progression-free survival (PFS) (P<0.01) and tended to correlate with shorter overall survival in patients with OCCC treated with platinum-based chemotherapy. When data were stratified for the multivariate analysis, only the loss of ARID1A expression remained a significant predictor of reduced PFS (P=0.03). Tumors with loss of ARID1A were more likely to be chemoresistant than tumors with positive ARID1A (100.0 vs 40.0%, P=0.04). This study demonstrates that loss of ARID1A in OCCC is a negative prognostic factor in patients. Measurement of ARID1A expression may be a method to predict resistance in patients with OCCC.

  • Research Products

    (21 results)

All 2013 2012 2011

All Journal Article (18 results) Presentation (3 results)

  • [Journal Article] ESR1 gene amplification in endometrial carcinomas : A clinicopathological analysis2013

    • Author(s)
      Rahman MT, Nakayama K, Rahman M, Ishikawa M, Katagiri H, Katagiri A, Ishibashi T, Sato E, Iida K, Nakayama N, Ishikawa N, Miyazaki K
    • Journal Title

      Anticancer Res.

      Volume: 33 Pages: 3775-3781

  • [Journal Article] KRAS and MAPK1 gene amplification in type II ovarian carcinomas2013

    • Author(s)
      Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Sato E, Iida K, Nakayama N, Ishikawa N, Miyazaki K
    • Journal Title

      Int J Mol Sci.

      Volume: 14 Pages: 13748-13762

  • [Journal Article] Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer2013

    • Author(s)
      Rahman MT, Nakayama K, Ishikawa M, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Iida K, Miyazaki K
    • Journal Title

      Oncology

      Volume: 84 Pages: 166-173

  • [Journal Article] PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes2013

    • Author(s)
      Rahman M, Nakayama K, Rahman MT, Nakayama N, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Otsuki Y, Nakayama S, Miyazaki K
    • Journal Title

      Anticancer Res.

      Volume: 33 Pages: 113-118

  • [Journal Article] Is ATP7B a predictive marker in patients with ovarian carcinoma treated with platinum-taxane combination chemotherapy?2013

    • Author(s)
      Katagiri H, Nakayama K, Rahman MT, Rahman M, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama S, Otsuki Y, Miyazaki K
    • Journal Title

      Int J Gynecol Cancer

      Volume: 23 Pages: 60-64

  • [Journal Article] Clinicopathological analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer2013

    • Author(s)
      Rahman M, Nakayama K, Rahman MT, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Miyazaki K
    • Journal Title

      Hum Pathol.

      Volume: 44 Pages: 103-109

  • [Journal Article] Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer2012

    • Author(s)
      Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama S, Otsuki S, Miyazaki K
    • Journal Title

      Am J Clin Pathol.

      Volume: 138 Pages: 535-544

  • [Journal Article] NAC1, a BTB/POZ protein overexpressed in uterine sarcomas2012

    • Author(s)
      Rahman MT, Nakayama K, Ishikawa M, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Iida K, Yamada T, Miyazaki K
    • Journal Title

      Anticancer Res.

      Volume: 32 Pages: 3841-3845

  • [Journal Article] Gene amplification of ZNF217 located at chr20q13.2 is associated with lymph node metastasis in ovarian clear cell carcinoma2012

    • Author(s)
      Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama N, Otsuki Y, Nakayama S, Miyazaki K
    • Journal Title

      Anticancer Res.

      Volume: 32 Pages: 3091-3095

  • [Journal Article] Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma2012

    • Author(s)
      R ahman M, Nakayama K, Rahman MT, Nakayama N, Ishikawa M, Katagiri A, Iida K, Nakayama S, Otsuki Y, Shih IeM, Miyazaki K
    • Journal Title

      Hum Pathol

      Volume: 43 Pages: 2197-2206

  • [Journal Article] Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas2012

    • Author(s)
      Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama N, Otsuki Y, Nakayama S, Miyazaki K
    • Journal Title

      Br J Cancer

      Volume: 107 Pages: 300-307

  • [Journal Article] Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix2012

    • Author(s)
      Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Ishikawa M, Ishibashi T, Iida K, Otsuki Y, Nakayama S, Miyazaki K
    • Journal Title

      Int J Gynecol Cancer

      Volume: 22 Pages: 208-212

  • [Journal Article] Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma2012

    • Author(s)
      Rahman MT, Nakayama K, Rahman M, Nakayama N, Ishikawa M, Katagiri A, Iida K, Nakayama S, Otsuki Y, Shih IeM, Miyazaki K
    • Journal Title

      Cancer

      Volume: 118 Pages: 2846-2857

  • [Journal Article] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma2012

    • Author(s)
      Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Nakayama N Ishikawa M, Ishibashi T, Iida K, Otsuki Y, Nakayama S, Miyazaki K
    • Journal Title

      Mod Pathol.

      Volume: 25 Pages: 282-288

  • [Journal Article] Biological and clinical significance of NAC1 expression in cervical carcinomas : a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas2012

    • Author(s)
      Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K
    • Journal Title

      Hum Pathol.

      Volume: 43 Pages: 506-519

  • [Journal Article] EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target2011

    • Author(s)
      Iida K, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Yeasmin S, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K
    • Journal Title

      Br J Cancer

      Volume: 105 Pages: 420-427

  • [Journal Article] MKK4 acts as a potential tumor suppressor in ovarian cancer2011

    • Author(s)
      Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Miyazaki K
    • Journal Title

      Tumour Biol.

      Volume: 32 Pages: 661-670

  • [Journal Article] Loss of MKK4 expression in ovarian cancer : a potential role for the epithelial to mesenchymal transition2011

    • Author(s)
      Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Miyazaki K
    • Journal Title

      Int J Cancer

      Volume: 128 Pages: 94-104

  • [Presentation] 卵巣癌におけるNAC1 pathwayに基づいた創薬への展開、(婦人科がんにおけるトランスレーショナルリサーチ、シーズの探索から臨床応用まで)2013

    • Author(s)
      石川雅子,中山健太郎、中山真美、片桐浩、片桐敦子、佐藤絵美、飯田幸司、Mohammed Tanjimur Rahman、Munmun Rahman、宮崎康二
    • Organizer
      The 3rd Biennial Meeting of ASGO
    • Place of Presentation
      ウエスティン都ホテル京都、京都市
    • Year and Date
      2013-12-15
  • [Presentation] 卵巣癌におけるNAC1 pathwayに基づいた創薬への展開、(婦人科がんにおけるトランスレーショナルリサーチ、シーズの探索から臨床応用まで)2013

    • Author(s)
      中山健太郎、中山真美、石川雅子、片桐浩、片桐敦子、佐藤絵美、飯田幸司、Mohammed Tanjimur Rahman、Munmun Rahman、宮崎康二
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜、横浜市
    • Year and Date
      2013-10-03
  • [Presentation] 新規癌関連転写因子NAC1を標的とした卵巣癌治療法の開発、(卵巣癌のMolecular Medicine)2013

    • Author(s)
      中山健太郎、石川雅子、片桐浩、片桐敦子、石橋朋佳、佐藤絵美、Mohammed Tanjimur Rahman、Munmun Rahman、飯田幸司、中山真美、宮崎康二
    • Organizer
      第54回日本婦人科腫瘍学会
    • Place of Presentation
      ホテルグランパシフィックLE DAIBA、東京
    • Year and Date
      2013-07-20

URL: 

Published: 2015-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi